The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary analysis of total neoadjuvant therapy for patients with locally advanced gastric (G) and gastroesophageal (GE) adenocarcinoma.
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; AIM Specialty Health; AIM Specialty Health; AIM Specialty Health; Asahi Kasei; Asahi Kasei; Asahi Kasei; Asahi Kasei; BASF; BASF; BASF; BASF; Helsinn Healthcare (Inst); Helsinn Healthcare (Inst); Helsinn Healthcare (Inst); Helsinn Healthcare (Inst); Immuneering; Immuneering; Immuneering; Immuneering; Napo Pharmaceuticals; Napo Pharmaceuticals; Napo Pharmaceuticals; Napo Pharmaceuticals; Oragenics; Oragenics; Oragenics; Oragenics; Pronova (Inst); Pronova (Inst); Pronova (Inst); Pronova (Inst); Vector Oncology; Vector Oncology; Vector Oncology; Vector Oncology
 
Katie Kanter
No Relationships to Disclose
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
Madeleine Fish
No Relationships to Disclose
 
Ryan David Nipp
No Relationships to Disclose
 
Emily E. Van Seventer
No Relationships to Disclose
 
Aparna Raj Parikh
Consulting or Advisory Role - Driver, Inc; Driver, Inc; Driver, Inc; Driver, Inc; Eisai; Eisai; Eisai; Eisai; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; PureTech; PureTech; PureTech; PureTech
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Tolero Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai
 
Jill N. Allen
No Relationships to Disclose
 
Bruce J. Giantonio
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I); Pfizer (I); Pfizer (I); Pfizer (I)
 
Florence Keane
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
Speakers' Bureau - OncLive; OncLive; OncLive; OncLive
 
Samuel J. Klempner
Stock and Other Ownership Interests - TP Therapeutics; TP Therapeutics; TP Therapeutics; TP Therapeutics
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Lilly; Lilly; Lilly; Lilly
Speakers' Bureau - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst); Leap Therapeutics (Inst)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Acworth Pharmaceuticals; Acworth Pharmaceuticals; Acworth Pharmaceuticals; MPM Capital; MPM Capital; MPM Capital; MPM Capital
Honoraria - Research to Practice; Research to Practice; Research to Practice; Research to Practice; UpToDate; UpToDate; UpToDate; UpToDate
Consulting or Advisory Role - Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Maverick Therapeutics; Maverick Therapeutics; Maverick Therapeutics; Maverick Therapeutics; MPM Capital; MPM Capital; MPM Capital; MPM Capital; Oncorus; Oncorus; Oncorus; Oncorus; TCR2 Therapeutics; TCR2 Therapeutics; TCR2 Therapeutics; TCR2 Therapeutics; Twentyeight-Seven Therapeutics; Twentyeight-Seven Therapeutics; Twentyeight-Seven Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst); Stand up to Cancer (Inst); Stand up to Cancer (Inst); Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; Johns Hopkins University Press; Johns Hopkins University Press; Johns Hopkins University Press; McGraw Hill Chapter Royalties; McGraw Hill Chapter Royalties; McGraw Hill Chapter Royalties; McGraw Hill Chapter Royalties
Other Relationship - TCR2 Therapeutics; TCR2 Therapeutics; TCR2 Therapeutics; TCR2 Therapeutics
 
Hugh G. Auchincloss
No Relationships to Disclose
 
Harald Ott
No Relationships to Disclose
 
Michael Lanuti
Honoraria - Emory University; Emory University; Emory University; Emory University; Holy Cross Hospital; Holy Cross Hospital; Holy Cross Hospital; Holy Cross Hospital
Research Funding - NIH; NIH; NIH; NIH; NIH; NIH; NIH; NIH; Stand up to Cancer; Stand up to Cancer; Stand up to Cancer; Stand up to Cancer
 
Christopher Morse
No Relationships to Disclose
 
John Thomas Mullen
No Relationships to Disclose
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics; Clinical Genomics; Clinical Genomics; Clinical Genomics; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Intrinsic LifeSciences (Inst); Intrinsic LifeSciences (Inst); Intrinsic LifeSciences (Inst); Intrinsic LifeSciences (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)